TCON News and Press, TRACON Pharmaceuticals Inc. From 04/08/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Moonshot Investor newsletter. To make sure you don’t miss any  of Tom’s potential 100x picks,  subscribe to his mailing list here . Rising Rates...

SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform...

The following slide deck was published by TRACON Pharmaceuticals, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: TRACON Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation

TRACON Pharmaceuticals, Inc. (TCON) Q4 2021 Earnings Conference Call March 15, 2022 04:30 PM ET Company Participants Charles Theuer - President & Chief Executive Officer Scott Brown - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Ed White - H.C. Wainwrigh...

Tracon press release (NASDAQ:TCON): Q4 GAAP EPS of -$0.40 misses by $0.04. Cash, cash equivalents and short-term investments were $24.1 million at December 31, 2021, compared to $36.1 million at December 31, 2020. For further details see: Tracon GAAP EPS of -$0.40 misses by $0.04

Announced FDA Approval of Amended ENVASARC Protocol, ENVASARC Interim Efficacy Data on Track for 2H22 Initiating combination trial of proprietary CTLA-4 with envafolimab in 2022 SAN DIEGO, March 15, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage bio...

Tracon Pharmaceuticals (NASDAQ:TCON) is scheduled to announce Q4 earnings results on Tuesday, Mar. 15, after market close. The consensus EPS estimate is -$0.36 and the consensus revenue estimate is $0.07M. Over the last 2 years, TCON has beaten EPS estimates 63% of the time and has ...

OTCPK:ANCUF, ATHX, CAL, CHMI, CLPR, FF, GOCO, HYRE, KODK, LFT, LOTZ, LX, MTN, OPNT, S, SFT, SMAR, SRG, SRGA, TCON, YALA, YY, ZDGE For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesday's close

SAN DIEGO, March 11, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform...

SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform...